Tyra Biosciences Statistics
NASDAQ: TYRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
20.39+0.15 (+0.74%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Tyra Biosciences by the numbers
Tyra Biosciences has a market capitalization of $1.40 billion based on 68.76M shares outstanding. With trailing EPS of $-2.41, Tyra Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.9% below its 50-day average and 33.1% below its 200-day average.
Average daily trading volume is 859.27K shares, or about $17.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TYRA valuation vs. peer median
| Metric | TYRA | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.40B | $1.38B | +1% |
| Avg. volume | 859.27K | 706.86K | +22% |
Peer median across 8 companies: AAPG, NKTR, KLRA, ANAB, OMER, KRSA, GHRS, RARE.
Valuation
- Market cap
- $1.40B
- EPS (TTM)
- $-2.41
- Shares outstanding
- 68.76M
Price and trading
- Previous close
- 20.24
- Open
- 19.97
- Day range
- 19.80 – 20.79
- 52-week range
- 13.29 – 40.65
- 52-week change
- +52.51%
- Beta
- —
- Volume
- 477.71K
- Average volume
- 859.27K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 1.40B
- Forward Pe
- -7.36
- Eps
- -2.41
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.65
- Week52 Low
- 13.29
- Avg Volume
- 859.27K
- Shares Outstanding
- 68.76M
- Ma50
- 25.47
- Ma200
- 30.49
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -49.84%
- Pct From52w Low
- 53.42%